Two promotions in Humatica’s London office

ndetails

Humatica, the leading private equity specialist advisor for portfolio organizational effectiveness, is proud to announce two promotions in its London office.

Lucas Lasagna Del Val has been promoted to Consultant. He contributed to the development and application of Humatica’s unique behavioural benchmarking tools across a portfolio of companies, as well as the implementation of best-practice after sales service processes in a mid-market buy-out.

Joshua Kilb has been promoted to Consultant. Joshua continued to demonstrate the entrepreneurial drive and maturity needed to effect positive change within Humatica’s clients. In particular, he was instrumental in facilitating the smooth transition to a new operating model and organizational set-up for a large-cap buy-out.

We would like to thank these two talented team members for their contributions and congratulate them on their promotions.

According to Managing Partner, Andros Payne:

Both Lucas and Joshua have demonstrated competence as valued Humatica team members and client advisors in diverse and tricky organisational transformation cases. We are pleased to see them take the growth opportunities we can offer to develop their professional skills.

Related News

Experienced Private Equity executive Melissa Mounce joins Humatica to build the firm’s presence in the US
17 Feb, 2025 By Humatica

Experienced Private Equity executive Melissa Mounce joins Humatica to build the firm’s presence in the US

Humatica, the leading private equity specialist advisor for organizational effectiveness, is pleased to announce that Melissa Mounce has joined the firm as an Operating Partner…

Read more arrowicon
Humatica finalist for two prestigious PE Awards
03 Feb, 2025 By Humatica

Humatica finalist for two prestigious PE Awards

Humatica has been named a finalist for the Actum Awards as Value Creation Firm of the Year (People and Organisational Strategy) and for the Real Deals Private Equity Awards 2025 in…

Read more arrowicon
Humatica 2024 in Review and Outlook 2025
17 Dec, 2024 By Humatica

Humatica 2024 in Review and Outlook 2025

2024 was a milestone year for private equity, and for Humatica. The industry is under greater pressure to generate acceptable returns than ever before. With…

Read more arrowicon